Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1984-7-27
|
pubmed:abstractText |
The effect of 1.25-dihydroxyvitamin D [1,25-(OH)2D] on dietary oxalate absorption and postprandial urine supersaturation with calcium oxalate was determined in 11 normal subjects. 1,25-(OH)2D increased the urinary excretion of orally administered [14C]oxalate in the 8 h period after a liquid meal containing 1.875 mmol of calcium and 0.83 mmol of oxalate (P less than 0.01), and during a 48 h period when the subjects ingested a diet containing 25 mmol of calcium and 3.3 mmol of oxalate/day (P less than 0.01); however, 1,25-(OH)2D administration had no effect on [14C]oxalate excretion when calcium was removed from the liquid meal. 1.25-(OH)2D increased 24 h urinary oxalate excretion from 28.7 +/- 2.1 mmol/mol of creatinine to 36.8 +/- 2.6 mmol/mol of creatinine (P less than 0.05) on the 10 mmol/day calcium diet and from 26.4 +/- 2.9 to 33.2 +/- 2.2 mmol/mol of creatinine (P less than 0.1) on the 25 mmol/day calcium diet. A linear correlation (r = 0.72) was found between plasma 1,25-(OH)2D levels and urinary [14C]oxalate excretion after the liquid meal. 1,25-(OH)2D administration produced postprandial supersaturation of urine with calcium oxalate and calcium oxalate crystalluria. These studies suggest that 1,25-(OH)2D increases oxalate absorption (and urinary excretion) by increasing calcium absorption, which results in less binding of calcium to oxalate in the intestine; therefore more oxalate is available for absorption. The combined effect of increased calcium and oxalate absorption results in postprandial supersaturation of urine with calcium oxalate, with resultant crystalluria.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcitriol,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Oxalate,
http://linkedlifedata.com/resource/pubmed/chemical/Oxalates,
http://linkedlifedata.com/resource/pubmed/chemical/Oxalic Acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0143-5221
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
131-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:6547378-Adult,
pubmed-meshheading:6547378-Calcitriol,
pubmed-meshheading:6547378-Calcium,
pubmed-meshheading:6547378-Calcium Metabolism Disorders,
pubmed-meshheading:6547378-Calcium Oxalate,
pubmed-meshheading:6547378-Crystallization,
pubmed-meshheading:6547378-Fasting,
pubmed-meshheading:6547378-Female,
pubmed-meshheading:6547378-Humans,
pubmed-meshheading:6547378-Intestinal Absorption,
pubmed-meshheading:6547378-Male,
pubmed-meshheading:6547378-Osmolar Concentration,
pubmed-meshheading:6547378-Oxalates,
pubmed-meshheading:6547378-Oxalic Acid
|
pubmed:year |
1984
|
pubmed:articleTitle |
Oxalate absorption and postprandial urine supersaturation in an experimental human model of absorptive hypercalciuria.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|